Clinical trials
Completed trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,409 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 12 |
| 2002 | 14 |
| 2003 | 28 |
| 2004 | 46 |
| 2005 | 59 |
| 2006 | 109 |
| 2007 | 115 |
| 2008 | 164 |
| 2009 | 160 |
| 2010 | 163 |
| 2011 | 184 |
| 2012 | 153 |
| 2013 | 123 |
| 2014 | 150 |
| 2015 | 148 |
| 2016 | 128 |
| 2017 | 115 |
| 2018 | 83 |
| 2019 | 89 |
| 2020 | 75 |
| 2021 | 63 |
| 2022 | 76 |
| 2023 | 62 |
| 2024 | 54 |
| 2025 | 21 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,409 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 122 |
| Hoffmann-La Roche | 115 |
| Eli Lilly and Company | 104 |
| GlaxoSmithKline | 102 |
| Sanofi | 96 |
| Novartis Pharmaceuticals | 82 |
| Pfizer | 69 |
| Boehringer Ingelheim | 67 |
| Bristol-Myers Squibb | 67 |
| Novo Nordisk A/S | 59 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 199 |
| Arthritis, Rheumatoid | 93 |
| Pulmonary Disease, Chronic Obstructive | 84 |
| Diabetes Mellitus | 80 |
| Asthma | 75 |
| Carcinoma, Non-Small-Cell Lung | 74 |
| Schizophrenia | 67 |
| Breast Neoplasms | 59 |
| Colitis, Ulcerative | 44 |
| Renal Insufficiency, Chronic | 44 |
Trials
Showing 1 to 25 of 2,409. Each trial links to its page on Pharma Observatory.
2,309 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.